Growing Industry Presence Synonym is positioning itself as a leading innovator in bioproduct development with recent collaborations such as the integration with Brenntag Group, expanding its market reach and customer base across global markets.

Innovative Tools Launch The launch of the Scaler platform offers synthetic biology companies critical cost projection tools, presenting opportunities to promote solutions that streamline production planning and reduce operational risks for clients scaling biomanufacturing operations.

Investment and Funding With a recent pre-seed investment of over 6 million dollars led by prominent venture firms, Synonym demonstrates strong financial backing and growth potential, making it a strategic partner for organizations seeking cutting-edge biomanufacturing solutions.

Strategic Collaborations Partnerships with organizations like the Material Innovation Initiative and GFI through projects like Capacitor create avenues for joint offerings and access to a network of innovative startups and established players interested in sustainable bioproducts.

Market Opportunity Synonym serves a diverse client base ranging from disruptors to Fortune 500 companies, indicating significant market demand for its integrated platforms and data services, ideal for targeting larger bio-focused companies and technology providers aiming to expand their sustainable product portfolios.